[Federal Register Volume 89, Number 37 (Friday, February 23, 2024)]
[Notices]
[Pages 13744-13745]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-03712]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-1322]


Bulk Manufacturer of Controlled Substances Application: Siemens 
Healthcare Diagnostics Inc.

AGENCY: Drug Enforcement Administration, Justice.

ACTION: Notice of application.

-----------------------------------------------------------------------

SUMMARY: Siemens Healthcare Diagnostics Inc. has applied to be 
registered as a bulk manufacturer of basic class(es) of controlled 
substance(s). Refer to Supplementary Information listed below for 
further drug information.

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may submit electronic comments on or 
objections to the issuance of the proposed registration on or before 
April 23, 2024. Such persons may also file a written request for a 
hearing on the application on or before April 23, 2024.

ADDRESSES: The Drug Enforcement Administration (DEA) requires that all 
comments be submitted electronically through the Federal eRulemaking 
Portal, which provides the ability to type short comments directly into 
the comment field on the web page or attach a file for lengthier 
comments. Please go to https://www.regulations.gov and follow the 
online instructions at that site for submitting comments. Upon 
submission of your comment, you will receive a Comment Tracking Number. 
Please be aware that submitted comments are not instantaneously 
available for public view on https://www.regulations.gov. If you have 
received a Comment Tracking Number, your comment has been successfully 
submitted and there is no need to resubmit the same comment.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this 
is notice that on January 10, 2024, Siemens Healthcare Diagnostics 
Inc., 100 GBC Drive, Mailstop 108, Newark, Delaware 19702-2461 applied 
to be registered as a bulk manufacturer of the following basic 
class(es) of controlled substance(s):

[[Page 13745]]



------------------------------------------------------------------------
                                           Drug
          Controlled substance             code          Schedule
------------------------------------------------------------------------
Ecgonine................................    9180  II
------------------------------------------------------------------------

    The company plans to produce the listed controlled substance in 
bulk to be used in the manufacture of the DEA exempt products. No other 
activities for this drug code is authorized for this registration.

Marsha Ikner,
Acting Deputy Assistant Administrator.
[FR Doc. 2024-03712 Filed 2-22-24; 8:45 am]
BILLING CODE P